SlideShare a Scribd company logo
Using an Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of
Streptococcus pneumoniae in Human Bodily Fluids
Jermaine D. Dorsey and Mamie T. Coats
Department of Biological Sciences, Alabama State University, Montgomery Alabama, USA, 36101
Abstract
Streptococcus pneumoniae is a major cause of
bacteremia, meningitis, and pneumonia in both
children and adults. Invasive pneumococcal
disease (IPD) primarily affects young children, older
adults (> 65 years of age), and individuals with
comorbidities or impaired immune systems. The
diagnosis of pneumococcal infections has been
attempted using methods which detect specific
antigens by the procedures of a quantitative
enzyme-linked immunosorbent assay (ELISA). We
will detect the antigen D39, WU2, and EF3030 for
the diagnosis of Streptococcus pneumoniae
infection.
Introduction
Streptococcus pneumoniae, pneumococcus, is a
gram-positive pathogen found in the upper respiratory
tract of healthy children and adults. Worldwide, S.
pneumoniae remains one of the leading cause of
community acquired bacterial infection for diseases
like; pneumonia, otitis media, bacterial meningitis,
and bacterium.
Pneumococcus polysaccharide capsule surrounds
the pneumococcus and protects it against clearance
by phagocytosis. More than 90 different capsule
serotypes have been discovered thus far.
When pneumococcal infection is suspected time is
very important in influencing patient outcomes.
Classical identification takes several days to verify
and molecular techniques are limited due to the
variability of the capsular polysaccharide. The overall
goal for this research is to develop a rapid, serotype
independent assay to detect S. pneumoniae in body
fluids in using an Enzyme-Linked Immuno-Sorbant
Assay.
.
• Coated 96-well plate with PspC specific polyclonal capture
antibody
• Blocked with Bovine Serum Albumin (BSA)
• Added 10X5 CFU/mL S. pneumoniae (strain D39, WU2)
• Added Detection antibody with incubation at 37°C
• Added labeled 2 antibody
• Added Substrate
• Read OD405
Discussion and future plan
• Overall, our experiment has shown that we
can detect PspC through ELISA Method.
• Use the same method in presence of bodily
fluids to determine the sensitivity of this
method of detection.
• Other virulence factors will be examined as
potential capture antigens.
Acknowledgements
I would like to thank my mentor and MARC U
STAR program, Biomedical Research and
Training Program at Alabama State University,
Montgomery, Al. 36104. This work was
supported by the National Institutes of Health
(NIH).
Methods and Results
Capture Antibody
Target Antigen
Detection
Antibody
Labeled Antibody
Biotin
Substrate
Anticipated results
0
1
2
3
4
5
6
7
1 2 3 4 5 6 7 8 9
LevelofPspCinEnvironment
(media)
Log CFU/mL
Free PspC
The level of
PspC in the
growth
environment is
directly
proportional to
the number of
pneumococci
present
The level of PspC
in the growth
patients’ samples
is directly
proportional to the
level of infection
and the site of
infection
pathmicro.med.sc.edu
0
2
4
6
8
10
12
Sputum
Blood
Infection level
AmountofPspCdetected

More Related Content

What's hot

Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;applicationFyzah Bashir
 
Lecture 9 molecular descriptors
Lecture 9  molecular descriptorsLecture 9  molecular descriptors
Lecture 9 molecular descriptors
RAJAN ROLTA
 
Glycan analysis of mAb’s_Introduction
Glycan analysis of mAb’s_IntroductionGlycan analysis of mAb’s_Introduction
Glycan analysis of mAb’s_Introduction
Sada Siva Rao Maddiguntla
 
NMR - KRISHNAN
NMR - KRISHNANNMR - KRISHNAN
NMR - KRISHNAN
KRISHNANMUTHUSAMY
 
Molar extinction coefficient
Molar extinction coefficientMolar extinction coefficient
Molar extinction coefficientDhruv Sharma
 
Applying Hidden Markov Models to Bioinformatics
Applying Hidden Markov Models to BioinformaticsApplying Hidden Markov Models to Bioinformatics
Applying Hidden Markov Models to Bioinformaticsbutest
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design ppt
Abhik Seal
 
Image J for analysis of biological image and nanoparticle size distribution
Image J for analysis of biological image and nanoparticle size distribution Image J for analysis of biological image and nanoparticle size distribution
Image J for analysis of biological image and nanoparticle size distribution
Thoria Donia
 
Metabolomics
Metabolomics Metabolomics
Metabolomics
soniyakasliwal
 
Lectut btn-202-ppt-l28. variants of pcr-ii
Lectut btn-202-ppt-l28. variants of pcr-iiLectut btn-202-ppt-l28. variants of pcr-ii
Lectut btn-202-ppt-l28. variants of pcr-ii
Rishabh Jain
 
Immunochemical techniques
Immunochemical techniquesImmunochemical techniques
Immunochemical techniques
Sagar Savale
 
Ligand based drug design
Ligand based drug designLigand based drug design
Ligand based drug design
Satyendra Yadav
 
BT631-22-Membrane_proteins
BT631-22-Membrane_proteinsBT631-22-Membrane_proteins
BT631-22-Membrane_proteinsRajesh G
 
DiGE....2-D gel electrophoresis
DiGE....2-D gel electrophoresisDiGE....2-D gel electrophoresis
DiGE....2-D gel electrophoresis
Karan Veer Singh
 
Snp
SnpSnp
Virtual screening ppt
Virtual screening pptVirtual screening ppt
Virtual screening ppt
VivekYadav490
 
Circular Dichroism Spectroscopy
Circular Dichroism SpectroscopyCircular Dichroism Spectroscopy
Circular Dichroism Spectroscopy
Aditya Sharma
 
Cish
CishCish
Biomolecular interaction analysis (BIA) techniques
Biomolecular interaction analysis (BIA) techniquesBiomolecular interaction analysis (BIA) techniques
Biomolecular interaction analysis (BIA) techniques
N Poorin
 
Microarray Analysis
Microarray AnalysisMicroarray Analysis
Microarray Analysis
James McInerney
 

What's hot (20)

Microarrays;application
Microarrays;applicationMicroarrays;application
Microarrays;application
 
Lecture 9 molecular descriptors
Lecture 9  molecular descriptorsLecture 9  molecular descriptors
Lecture 9 molecular descriptors
 
Glycan analysis of mAb’s_Introduction
Glycan analysis of mAb’s_IntroductionGlycan analysis of mAb’s_Introduction
Glycan analysis of mAb’s_Introduction
 
NMR - KRISHNAN
NMR - KRISHNANNMR - KRISHNAN
NMR - KRISHNAN
 
Molar extinction coefficient
Molar extinction coefficientMolar extinction coefficient
Molar extinction coefficient
 
Applying Hidden Markov Models to Bioinformatics
Applying Hidden Markov Models to BioinformaticsApplying Hidden Markov Models to Bioinformatics
Applying Hidden Markov Models to Bioinformatics
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design ppt
 
Image J for analysis of biological image and nanoparticle size distribution
Image J for analysis of biological image and nanoparticle size distribution Image J for analysis of biological image and nanoparticle size distribution
Image J for analysis of biological image and nanoparticle size distribution
 
Metabolomics
Metabolomics Metabolomics
Metabolomics
 
Lectut btn-202-ppt-l28. variants of pcr-ii
Lectut btn-202-ppt-l28. variants of pcr-iiLectut btn-202-ppt-l28. variants of pcr-ii
Lectut btn-202-ppt-l28. variants of pcr-ii
 
Immunochemical techniques
Immunochemical techniquesImmunochemical techniques
Immunochemical techniques
 
Ligand based drug design
Ligand based drug designLigand based drug design
Ligand based drug design
 
BT631-22-Membrane_proteins
BT631-22-Membrane_proteinsBT631-22-Membrane_proteins
BT631-22-Membrane_proteins
 
DiGE....2-D gel electrophoresis
DiGE....2-D gel electrophoresisDiGE....2-D gel electrophoresis
DiGE....2-D gel electrophoresis
 
Snp
SnpSnp
Snp
 
Virtual screening ppt
Virtual screening pptVirtual screening ppt
Virtual screening ppt
 
Circular Dichroism Spectroscopy
Circular Dichroism SpectroscopyCircular Dichroism Spectroscopy
Circular Dichroism Spectroscopy
 
Cish
CishCish
Cish
 
Biomolecular interaction analysis (BIA) techniques
Biomolecular interaction analysis (BIA) techniquesBiomolecular interaction analysis (BIA) techniques
Biomolecular interaction analysis (BIA) techniques
 
Microarray Analysis
Microarray AnalysisMicroarray Analysis
Microarray Analysis
 

Similar to ELISA Poster Presentation 2012 RCA 5 mtc

16. investigation of infection
16. investigation of infection16. investigation of infection
16. investigation of infection
Ahmad Hamadi
 
Disease diagnosis techniques
Disease diagnosis techniquesDisease diagnosis techniques
Disease diagnosis techniques
naveenGorana
 
Laboratory diagnosis of (hiv)
Laboratory diagnosis of  (hiv)Laboratory diagnosis of  (hiv)
Laboratory diagnosis of (hiv)
abdulrahman amer
 
Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...
Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...
Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...
IOSR Journals
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisAbhijit Chaudhury
 
Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...
Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...
Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...
Dr. Shameeran Bamarni
 
lab diagnosis of viral diseases
lab diagnosis of viral diseaseslab diagnosis of viral diseases
The problem and Its Background
The problem and Its BackgroundThe problem and Its Background
The problem and Its Background
Moris Santos
 
Laboratory diagnosis of Tuberculosis gs
Laboratory diagnosis of Tuberculosis gs Laboratory diagnosis of Tuberculosis gs
Laboratory diagnosis of Tuberculosis gs
Gaurav S
 
Vaccine clinical trial
Vaccine clinical trialVaccine clinical trial
Vaccine clinical trialPiyush Bafna
 
Microbiological Culture sensitivity tests
Microbiological Culture sensitivity testsMicrobiological Culture sensitivity tests
Microbiological Culture sensitivity tests
Dr Vimali
 
LABORATORY DIAGNOSIS OF HIV - AIDS
LABORATORY DIAGNOSIS OF HIV - AIDSLABORATORY DIAGNOSIS OF HIV - AIDS
LABORATORY DIAGNOSIS OF HIV - AIDS
Ashish Jawarkar
 
Antibiotic assay in blood and other body fluids
Antibiotic assay in blood and other body fluidsAntibiotic assay in blood and other body fluids
Antibiotic assay in blood and other body fluids
Seni MB
 
SEMINARIO BIOMOL - Isabella Buitrago
SEMINARIO BIOMOL - Isabella Buitrago SEMINARIO BIOMOL - Isabella Buitrago
SEMINARIO BIOMOL - Isabella Buitrago
isabellabuitrago4
 
Genotypic study documents divergence in the pathogenesis of bloodstream infec...
Genotypic study documents divergence in the pathogenesis of bloodstream infec...Genotypic study documents divergence in the pathogenesis of bloodstream infec...
Genotypic study documents divergence in the pathogenesis of bloodstream infec...
Danny Zuluaga
 
Lab diagnosis of infectious disease
Lab diagnosis of infectious disease Lab diagnosis of infectious disease
Lab diagnosis of infectious disease
Zakir H. Habib
 
Special Investigations
Special Investigations Special Investigations
Special Investigations
RGCL
 
Genetic study of torch infections in women with bad obstetric history multipl...
Genetic study of torch infections in women with bad obstetric history multipl...Genetic study of torch infections in women with bad obstetric history multipl...
Genetic study of torch infections in women with bad obstetric history multipl...
Alexander Decker
 
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Healthcare and Medical Sciences
 
Serological test for fungi
Serological test for  fungiSerological test for  fungi
Serological test for fungi
Meenakshi Muthuswamy
 

Similar to ELISA Poster Presentation 2012 RCA 5 mtc (20)

16. investigation of infection
16. investigation of infection16. investigation of infection
16. investigation of infection
 
Disease diagnosis techniques
Disease diagnosis techniquesDisease diagnosis techniques
Disease diagnosis techniques
 
Laboratory diagnosis of (hiv)
Laboratory diagnosis of  (hiv)Laboratory diagnosis of  (hiv)
Laboratory diagnosis of (hiv)
 
Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...
Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...
Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis...
 
Laboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosisLaboratory diagnosis of toxoplasmosis
Laboratory diagnosis of toxoplasmosis
 
Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...
Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...
Diagnostic methods and protocols used in investigating Toxoplasma gondii in h...
 
lab diagnosis of viral diseases
lab diagnosis of viral diseaseslab diagnosis of viral diseases
lab diagnosis of viral diseases
 
The problem and Its Background
The problem and Its BackgroundThe problem and Its Background
The problem and Its Background
 
Laboratory diagnosis of Tuberculosis gs
Laboratory diagnosis of Tuberculosis gs Laboratory diagnosis of Tuberculosis gs
Laboratory diagnosis of Tuberculosis gs
 
Vaccine clinical trial
Vaccine clinical trialVaccine clinical trial
Vaccine clinical trial
 
Microbiological Culture sensitivity tests
Microbiological Culture sensitivity testsMicrobiological Culture sensitivity tests
Microbiological Culture sensitivity tests
 
LABORATORY DIAGNOSIS OF HIV - AIDS
LABORATORY DIAGNOSIS OF HIV - AIDSLABORATORY DIAGNOSIS OF HIV - AIDS
LABORATORY DIAGNOSIS OF HIV - AIDS
 
Antibiotic assay in blood and other body fluids
Antibiotic assay in blood and other body fluidsAntibiotic assay in blood and other body fluids
Antibiotic assay in blood and other body fluids
 
SEMINARIO BIOMOL - Isabella Buitrago
SEMINARIO BIOMOL - Isabella Buitrago SEMINARIO BIOMOL - Isabella Buitrago
SEMINARIO BIOMOL - Isabella Buitrago
 
Genotypic study documents divergence in the pathogenesis of bloodstream infec...
Genotypic study documents divergence in the pathogenesis of bloodstream infec...Genotypic study documents divergence in the pathogenesis of bloodstream infec...
Genotypic study documents divergence in the pathogenesis of bloodstream infec...
 
Lab diagnosis of infectious disease
Lab diagnosis of infectious disease Lab diagnosis of infectious disease
Lab diagnosis of infectious disease
 
Special Investigations
Special Investigations Special Investigations
Special Investigations
 
Genetic study of torch infections in women with bad obstetric history multipl...
Genetic study of torch infections in women with bad obstetric history multipl...Genetic study of torch infections in women with bad obstetric history multipl...
Genetic study of torch infections in women with bad obstetric history multipl...
 
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
 
Serological test for fungi
Serological test for  fungiSerological test for  fungi
Serological test for fungi
 

ELISA Poster Presentation 2012 RCA 5 mtc

  • 1. Using an Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Streptococcus pneumoniae in Human Bodily Fluids Jermaine D. Dorsey and Mamie T. Coats Department of Biological Sciences, Alabama State University, Montgomery Alabama, USA, 36101 Abstract Streptococcus pneumoniae is a major cause of bacteremia, meningitis, and pneumonia in both children and adults. Invasive pneumococcal disease (IPD) primarily affects young children, older adults (> 65 years of age), and individuals with comorbidities or impaired immune systems. The diagnosis of pneumococcal infections has been attempted using methods which detect specific antigens by the procedures of a quantitative enzyme-linked immunosorbent assay (ELISA). We will detect the antigen D39, WU2, and EF3030 for the diagnosis of Streptococcus pneumoniae infection. Introduction Streptococcus pneumoniae, pneumococcus, is a gram-positive pathogen found in the upper respiratory tract of healthy children and adults. Worldwide, S. pneumoniae remains one of the leading cause of community acquired bacterial infection for diseases like; pneumonia, otitis media, bacterial meningitis, and bacterium. Pneumococcus polysaccharide capsule surrounds the pneumococcus and protects it against clearance by phagocytosis. More than 90 different capsule serotypes have been discovered thus far. When pneumococcal infection is suspected time is very important in influencing patient outcomes. Classical identification takes several days to verify and molecular techniques are limited due to the variability of the capsular polysaccharide. The overall goal for this research is to develop a rapid, serotype independent assay to detect S. pneumoniae in body fluids in using an Enzyme-Linked Immuno-Sorbant Assay. . • Coated 96-well plate with PspC specific polyclonal capture antibody • Blocked with Bovine Serum Albumin (BSA) • Added 10X5 CFU/mL S. pneumoniae (strain D39, WU2) • Added Detection antibody with incubation at 37°C • Added labeled 2 antibody • Added Substrate • Read OD405 Discussion and future plan • Overall, our experiment has shown that we can detect PspC through ELISA Method. • Use the same method in presence of bodily fluids to determine the sensitivity of this method of detection. • Other virulence factors will be examined as potential capture antigens. Acknowledgements I would like to thank my mentor and MARC U STAR program, Biomedical Research and Training Program at Alabama State University, Montgomery, Al. 36104. This work was supported by the National Institutes of Health (NIH). Methods and Results Capture Antibody Target Antigen Detection Antibody Labeled Antibody Biotin Substrate Anticipated results 0 1 2 3 4 5 6 7 1 2 3 4 5 6 7 8 9 LevelofPspCinEnvironment (media) Log CFU/mL Free PspC The level of PspC in the growth environment is directly proportional to the number of pneumococci present The level of PspC in the growth patients’ samples is directly proportional to the level of infection and the site of infection pathmicro.med.sc.edu 0 2 4 6 8 10 12 Sputum Blood Infection level AmountofPspCdetected